GB0222276D0 - Methods - Google Patents

Methods

Info

Publication number
GB0222276D0
GB0222276D0 GBGB0222276.8A GB0222276A GB0222276D0 GB 0222276 D0 GB0222276 D0 GB 0222276D0 GB 0222276 A GB0222276 A GB 0222276A GB 0222276 D0 GB0222276 D0 GB 0222276D0
Authority
GB
United Kingdom
Prior art keywords
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0222276.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Molecular and Cell Biology
Original Assignee
Institute of Molecular and Cell Biology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Molecular and Cell Biology filed Critical Institute of Molecular and Cell Biology
Priority to GBGB0222276.8A priority Critical patent/GB0222276D0/en
Publication of GB0222276D0 publication Critical patent/GB0222276D0/en
Priority to PCT/SG2003/000228 priority patent/WO2004029295A1/en
Priority to AU2003263728A priority patent/AU2003263728A1/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0331—Animal model for proliferative diseases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GBGB0222276.8A 2002-09-25 2002-09-25 Methods Ceased GB0222276D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0222276.8A GB0222276D0 (en) 2002-09-25 2002-09-25 Methods
PCT/SG2003/000228 WO2004029295A1 (en) 2002-09-25 2003-09-23 Method for diagnosis of cancer
AU2003263728A AU2003263728A1 (en) 2002-09-25 2003-09-23 Method for diagnosis of cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0222276.8A GB0222276D0 (en) 2002-09-25 2002-09-25 Methods

Publications (1)

Publication Number Publication Date
GB0222276D0 true GB0222276D0 (en) 2002-10-30

Family

ID=9944761

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0222276.8A Ceased GB0222276D0 (en) 2002-09-25 2002-09-25 Methods

Country Status (3)

Country Link
AU (1) AU2003263728A1 (en)
GB (1) GB0222276D0 (en)
WO (1) WO2004029295A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG120191A1 (en) * 2004-09-01 2006-03-28 Agency Science Tech & Res Methods
US8735082B2 (en) 2008-11-10 2014-05-27 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Gene signature for predicting prognosis of patients with solid tumors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2269641A1 (en) * 1996-11-07 1998-05-14 The Board Of Trustees Of The Leland Stanford Junior University Sprouty protein and coding sequence
US20020164790A1 (en) * 1999-12-07 2002-11-07 David Warburton Lung stem cells and lung regeneration
DE60128685T2 (en) * 2000-06-23 2009-03-05 Bayer Schering Pharma Aktiengesellschaft COMPOSITIONS INTERFERING TO VEGF / VEGF AND ANGIOPOIETIN / TIE RECEPTOR FUNCTIONS
WO2002059271A2 (en) * 2001-01-25 2002-08-01 Gene Logic, Inc. Gene expression profiles in breast tissue
AU2003217942A1 (en) * 2002-03-01 2003-09-16 Rigel Pharmaceuticals, Inc. Modulators of leukocyte activation, compositions, and methods of use

Also Published As

Publication number Publication date
WO2004029295A1 (en) 2004-04-08
AU2003263728A1 (en) 2004-04-19

Similar Documents

Publication Publication Date Title
AU2003249738A8 (en) Ostoscope
AU2003297193A8 (en) Meta-web
DE50309217D1 (en) Benzimidazolderivate
AU2003252028A8 (en) Heterodiamondoids
AU2003279495A8 (en) Alert-modeling
DE50303619D1 (en) Reibschweissvorrichtung
DE50308027D1 (en) Cyclohexyl-harnstoff-derivate
DE50307787D1 (en) Isophthalsäurederivate
GB0208928D0 (en) Methods
AU2002367810A8 (en) Bis-transition-metal-chelate-probes
AU2003264900A8 (en) Cast-cutter
GB0220045D0 (en) Methods
DE50304964D1 (en) Handhobelmaschine
GB0221711D0 (en) Methods
AU2003262681A8 (en) Hemo-aide
DE10392833D2 (en) Geotextilie
GB0219723D0 (en) Methods
GB0204967D0 (en) Methods
AU2002341221A8 (en) Honey-brandy
AU2003253735A8 (en) Vacuolins
GB0202213D0 (en) Methods
GB0222276D0 (en) Methods
DE50309021D1 (en) Etherlacton
GB0213579D0 (en) Methods
GB0200526D0 (en) Methods

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)